Ads
related to: acute leukemia survival rate- About AML
What Is AML
AML Treatment
- Oral Treatment
That You Can Take At Home
Find Out More
- Download Patient Info
View Patient Assistance Resources
Register to Learn More
- Register for More Info
Receive Patient Resources
Get Additional Support
- Treatment Safety
Possible Side Effects
Important Safety Info
- View Patient Information
Download Patient Brochures
Learn More
- About AML
Search results
Novel CAR T therapy and shorter targeted therapy durations show promise for patients with leukemia
Medical Xpress· 5 days ago(ASCO) Annual Meeting. The novel anti-CD19 autologous chimeric antigen receptor (CAR) T cell therapy...
Autolus reports promising results for obe-cel in leukemia study By Investing.com
Investing.com· 5 days agoThe findings were presented at the American Society of Clinical..., the data revealed that the...
MD Anderson Research Highlights for June 5, 2024 | Newswise
Newswise· 22 hours agoThe University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These
Experimental therapy shows promise in pancreatic cancer clinical trial
Medical Xpress· 5 days agoIt acts by inflaming the microenvironment surrounding the tumor and thereby augmenting the activity...
Experimental Therapy Shows Promise in Pancreatic C | Newswise
Newswise· 7 days agoWASHINGTON --- Clinicians at Georgetown University’s Lombardi Comprehensive Cancer Center reported promising preliminary findings based on outcomes in the first six patients with metastatic ...
Gilead's (GILD) Urothelial Cancer Study Did Not Meet Its Primary Goal
Zacks via Yahoo Finance· 5 days agoGilead Sciences, Inc.'s (GILD) confirmatory TROPiCS-04 study on Trodelvy in locally advanced or...
Blenrep-Based Regimen Yields PFS Benefit in Relapsed/Refractory Myeloma
MedPage Today· 4 days agoProgression-free survival (PFS) was significantly higher with belantamab mafodotin (belamaf;...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 2 days agoLive from ASCO 2024 | Updated Data of Bcl-2 Inhibitor Lisaftoclax Combined with Azacitidine in Patients with AML Demonstrate Promising Efficacy and Manageable Safety PR Newswire SUZHOU, China ...
Kinder, Gentler Regimen for Classical Hodgkin Prevails in Randomized Trial
MedPage Today· 5 days agoReplacing chemotherapy with a targeted agent resulted in a better tolerated regimen for advanced...
Understanding CAR T-cell therapy: A conversation with Northside’s Dr. Melhem Solh - Atlanta Business...
The Business Journals· 2 days agoDr. Melhem Solh, medical director of the cellular therapy program at Northside Hospital, answers...
Ad
related to: acute leukemia survival rate